South & Central America Bioprocessing Market Forecast to 2031
South & Central America Bioprocessing Market Forecast to 2031 – Regional Analysis – by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Proliferating Demand for Personalized Medicine Fuels South & Central America Bioprocessing Market
The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle health concerns such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products-many of them for a relatively small group of patients. Therefore, a fundamentally different approach to the production and delivery of biological products may be required. Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The growing number of orphan diseases has increased the demand for biologics and drugs, which has subsequently boosted the growth of personalized medicines. In 2019, the FDA approved ~12 personalized medications for addressing the root causes of disease and further integrated precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program focuses on the innovation of genomics and informatics tools for better diagnosis and treatment of disease. Personalized medicines leverage advances in genetics and bioinformatics to target specific patient populations and treat previously untreatable diseases. Personalized medicine uses bioprocessing techniques to develop tailored therapies. From isolating specific cells to developing patient-specific treatments, bioprocessing steps are essential for producing treatments tailored to each patient. Therefore, the rising demand for personalized medicine is predicted to offer significant growth opportunities to the players operating in the bioprocessing market during the forecast period.
South & Central America Bioprocessing Market Overview
The South & Central America bioprocessing market is divided into Brazil, Argentina, and the Rest of South & Central America. Brazil is estimated to hold a major share of the market in this region during the forecast period. The market players invest heavily in R&D to stay ahead of the competition by offering innovative products. Further, improving local regulations encourages multinational biotechnology companies to set foot in South & Central American countries to manufacture and commercialize their products. For their geographic expansion, several global biotech companies have chosen the Brazilian market in the past due to their growing economy. Therefore, a surge in various research activities, rising healthcare expenditure, enhancements in the potential of treatments against cancer and autoimmune disorders, growing investments in biotechnology, and increasing research collaborations for developing a strong drug portfolio would create opportunities for the bioprocessing market in South & Central America in the coming years.
South & Central America Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)
South & Central America Bioprocessing Market Segmentation
The South & Central America bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.
Based on product, the South & Central America bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.
In terms of scale of operation, the South & Central America bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.
By process, the South & Central America bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.
Based on application, the South & Central America bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.
In terms of end user, the South & Central America bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.
By country, the South & Central America bioprocessing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioprocessing market share in 2023.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the South & Central America bioprocessing market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to Business Market Insights’ research, the South & Central America bioprocessing market was valued at US$ 892.42 million in 2023 and is expected to reach US$ 2,205.64 million by 2031, registering a CAGR of 12.0% from 2023 to 2031. Shift toward automated cell therapy manufacturing and growing biopharmaceutical industry are among the critical factors attributed to drive the South & Central America bioprocessing market growth.
A rising number of cell therapies have shifted the production of cell therapy products from a small volume to a large volume worldwide. Increasing research activities in cell therapies have led to a rise in the demand for advanced manufacturing solutions. In view of this, many players are offering products to meet the needs of academic researchers and large biotechnology companies. For instance, the Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. In addition, the evolution of cell therapy-from an academic and clinical setting to mass production and commercialization-is increasing the demand for automation in manufacturing. In May 2019, GE Healthcare launched the Chronicle web application to support the complete cell therapy workflow. Chronicle automation software is a good manufacturing practice-compliant digital solution designed to optimize complex cell therapy process development and manufacturing. Companies are also entering into strategic and technological developments for automation in cell therapy. For instance, in July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop and manufacture processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the fitness of T-cells and support the development of an integrated cGMP-compliant platform (system and software) along with reagents, consumables, and instruments. In March 2019, Lonza partnered with Israel’s Sheba Medical Center to provide automated and closed CAR-T manufacturing using its point-of-care Cocoon cell therapy manufacturing platform. Automated procedures can drastically reduce the production cost and enhance staff productivity and retention rates. Other than these factors, automated processes restrict various possible sources of contamination in the manufacturing unit and eventually enhance process consistency, which results in overall good quality products by reducing manual errors. Thus, the increasing adoption of automation among cell therapy manufacturers and the growing product innovations in the field of cell therapy are likely to boost cell therapy bioprocessing or manufacturing.
On the contrary, stringent regulatory policies and limitations associated with bioprocessing hamper the growth of South & Central America bioprocessing market.
Based on product, the South & Central America bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held 67.3% market share in 2023, amassing US$ 600.38 million. It is projected to garner US$ 1,536.41 million by 2031 to register 12.5% CAGR during 2023-2031. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.
In terms of scale of operation, the South & Central America bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held 80.5% share of South & Central America bioprocessing market in 2023, amassing US$ 718.16 million. It is anticipated to garner US$ 1,827.69 million by 2031 to expand at 12.4% CAGR during 2023-2031.
By process, the South & Central America bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess aids segment held 61.0% share of South & Central America bioprocessing market in 2023, amassing US$ 544.55 million. It is projected to garner US$ 1,376.04 million by 2031 to expand at 12.3% CAGR from 2023 to 2031.
Based on application, the South & Central America bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held 39.0% share of South & Central America bioprocessing market in 2023, amassing US$ 347.77 million. It is predicted to garner US$ 804.89 million by 2031 to expand at 11.1% CAGR between 2023 and 2031.
In terms of end user, the South & Central America bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies held 53.4% share of South & Central America bioprocessing market in 2023, amassing US$ 476.81 million. It is estimated to garner US$ 1,195.72 million by 2031 to expand at 12.2% CAGR during 2023-2031.
By country, the South & Central America bioprocessing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 66.6% share of South & Central America bioprocessing market in 2023. It was assessed at US$ 594.44 million in 2023 and is likely to hit US$ 1,498.73 million by 2031, registering a CAGR of 12.3% during 2023-2031.
Key players operating in the South & Central America bioprocessing market are Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Agilent Technologies Inc, and Cytiva US LLC, among others.
In January 2024, Agilent Technologies Inc. announced an agreement with Incyte to bring together Agilent’s expertise and proven track record in developing companion diagnostics (CDx) to support the development and commercialization of Incyte’s hematology and oncology portfolio.
In February 2024, Cytiva and LevitasBio collaborated to deliver an innovative single-cell workflow for genomics researchers in academia and industry. This collaboration marked a significant milestone in improving how samples are prepared, enabling researchers to quickly perform tasks like breaking down tissues and purifying individual cell suspensions for single-cell analysis and other downstream applications. This is particularly important for advancing personalized medicine by providing insights into disease mechanisms and therapeutic targets, supporting oncology research, and accelerating scientific discovery.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioprocessing market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Bioprocessing Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Biopharmaceutical Industry
4.2 Market Restraints
4.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
4.3 Market Opportunities
4.3.1 Proliferating Demand for Personalized Medicine
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact of Drivers and Restraints:
5. Bioprocessing Market – South & Central America Analysis
5.1 South & Central America Bioprocessing Market Overview
5.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
6. South & Central America Bioprocessing Market Analysis – by Product
6.1 Overview
6.2 Instruments
6.2.1 Overview
6.2.2 Instruments: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
6.2.2.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Instruments
6.2.2.1.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Bioreactors
6.2.2.1.2 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Chromatography Systems
6.3 Consumables & Accessories
6.3.1 Overview
6.3.2 Consumables & Accessories: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Consumables & Accessories
7. South & Central America Bioprocessing Market Analysis – by Scale of Operation
7.1 Overview
7.2 Commercial Operations
7.2.1 Overview
7.2.2 Commercial Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Clinical Operations
7.3.1 Overview
7.3.2 Clinical Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Bioprocessing Market Analysis – by Process
8.1 Overview
8.2 Downstream Bioprocess
8.2.1 Overview
8.2.2 Downstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Upstream Bioprocess
8.3.1 Overview
8.3.2 Upstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Bioprocessing Market Analysis – by Application
9.1 Overview
9.2 Monoclonal Antibodies
9.2.1 Overview
9.2.2 Monoclonal Antibodies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccines: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Recombinant Protein
9.4.1 Overview
9.4.2 Recombinant Protein: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Cell & Gene Therapy
9.5.1 Overview
9.5.2 Cell & Gene Therapy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Bioprocessing Market Analysis – by End User
10.1 Overview
10.2 Biopharmaceutical Companies
10.2.1 Overview
10.2.2 Biopharmaceutical Companies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Contract Manufacturing Organization
10.3.1 Overview
10.3.2 Contract Manufacturing Organization: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11. South & Central America Bioprocessing Market – Country Analysis
11.1 South & Central America
11.1.1 South & Central America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
11.1.1.1 Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.1.1 Overview
11.1.1.2 Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.2.1 Brazil: Bioprocessing Market Breakdown, by Product
11.1.1.2.1.1 Brazil: Bioprocessing Market Breakdown, by Instruments
11.1.1.2.1.1.1 Brazil: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.2.1.1.2 Brazil: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.2.1.2 Brazil: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.2.2 Brazil: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.2.3 Brazil: Bioprocessing Market Breakdown, by Process
11.1.1.2.4 Brazil: Bioprocessing Market Breakdown, by Application
11.1.1.2.5 Brazil: Bioprocessing Market Breakdown, by End User
11.1.1.3 Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.3.1 Overview
11.1.1.4 Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.4.1 Argentina: Bioprocessing Market Breakdown, by Product
11.1.1.4.1.1 Argentina: Bioprocessing Market Breakdown, by Instruments
11.1.1.4.1.1.1 Argentina: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.4.1.1.2 Argentina: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.4.1.2 Argentina: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.4.2 Argentina: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.4.3 Argentina: Bioprocessing Market Breakdown, by Process
11.1.1.4.4 Argentina: Bioprocessing Market Breakdown, by Application
11.1.1.4.5 Argentina: Bioprocessing Market Breakdown, by End User
11.1.1.5 Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.6.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Product
11.1.1.6.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Instruments
11.1.1.6.1.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.6.1.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.6.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.6.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.6.3 Rest of South & Central America: Bioprocessing Market Breakdown, by Process
11.1.1.6.4 Rest of South & Central America: Bioprocessing Market Breakdown, by Application
11.1.1.6.5 Rest of South & Central America: Bioprocessing Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Bioprocessing Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Getinge AB
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Corning Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 3M Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eppendorf SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cytiva US LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Research Team
14.2 Glossary of Terms
Table 1. South & Central America Bioprocessing Market Segmentation
Table 2. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Instruments
Table 3. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Bioreactors
Table 4. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Chromatography Systems
Table 5. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Consumables & Accessories
Table 6. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 7. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 8. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 9. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 10. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 11. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 12. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 13. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 14. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 15. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 16. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 17. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 18. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 19. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 20. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 21. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 22. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 23. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 24. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 25. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 26. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 27. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 28. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 29. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 30. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 31. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 32. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 33. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 34. Recent Organic Growth Strategies in the Bioprocessing Market
Table 35. Glossary of Terms, Bioprocessing Market
Figure 1. South & Central America Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) – by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) – by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) – by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) – by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) – by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. South & Central America: Bioprocessing Market, by Key Country – Revenue (2023) (US$ Million)
Figure 25. South & Central America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. Growth Strategies in the Bioprocessing Market
The List of Companies – South & Central America Bioprocessing Market
o Getinge AB
o Thermo Fisher Scientific Inc
o Sartorius AG
o Corning Inc
o Bio-Rad Laboratories Inc
o Merck KGaA
o 3M Co
o Eppendorf SE
o Agilent Technologies Inc
o Cytiva US LLC.
You must be logged in to post a review.
Reviews
There are no reviews yet.